Drug manufacturer, GlaxoSmithKline Consumer Nigeria Plc, has released its consolidated financial statements for half-year 2019. Information contained in the result shows that the company performed well across all major financial indicators.
Revenue: GSK Nigeria’s revenue stood at N9.6 billion in half-year 2019 as against N8.5 billion in H1 2018. The company recorded a 15.9% increase in revenue despite the rise in cost of sale from N6.3 billion in H1 2018 to N6.5 in H1 2019.
Profit Before Tax: PBT stood at N531.5 million in H1 2019, indicating a 2.8% increase when compared to N517.2 recorded in H1 2018.
Profit After Tax: Profit for the half-year period also increased by 2.8% to N372 million compared to N362 million recorded in H1 2018.
Earnings Per Share stood at 31 kobo as against 30 kobo during the comparable period last year.
See the H1 2019 result HERE.
